Commentary: Tirbanibulin ointment for actinic keratosis
By Bob Kronemyer | Reviewed by Drs. Tyring, Schlesinger, and Lain Tirbanibulin 1% ointment (Klisyri; Almirall SA) for treating actinic keratosis of the face and scalp is now commercially available in the United States. Results of 2 identically designed phase 3 trials of the drug, which was FDA-approved in December 2020, were recently published in […]